What is the current share price of NH3 Clean Energy Limited (NH3)? NH3 Clean Energy Limited's (NH3) current share price is $0.08. This constitutes a price movement of 53.85% when compared to the share ...

WinGD has marked a major milestone in maritime decarbonisation, reportedly becoming the first engine designer to bring an ammonia-fuelled two-stroke engine to market The X52DF-A engine has been ...

Abstract: Black silicon (B-Si) has been extensively applied in the photovoltaic field for its prominent light-trapping feature, but its large surface area also brings plenty of structural defects. In ...

Abstract: Achieving long-duration, large bulk GaN growth is crucial to supply low-cost, high-quality GaN. Halogen-free vapor phase epitaxy (HF-VPE) is a promising method for bulk GaN growth but faces ...

NH3 Clean Energy has signed an agreement with Pilbara Ports Authority to explore the decarbonisation of iron ore shipments from the Port of Dampier in Western Australia. Phase one of the project would ...

Data supplied by Morningstar and accurate on Sep 15, 2025. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

It's small and modest compared to the giant ships and vessels that also claim to pioneer a green shipping era, but it's just as powerful and important in terms of innovation. Although almost half a ...

On Sept. 23, ammonia-to-power solution company, Amogy, released a statement announcing that the world’s first ammonia-powered maritime vessel successfully completed its maiden voyage. The NH 3 Kraken, ...

Python 3.10 to 3.13 supported. Django 3.2 to 5.1 supported. The project is in it's infancy, setup because of bleach becoming deprecated. It is setup with pre-commit to maintain code quality. This ...

ABSTRACT: This study focuses on air quality in southern Benin in order to show public authorities what the Beninese populations are exposed to for efficient decision-making. Two sampling campaigns ...

Endocrine therapy that blocks estrogen receptor signaling has been effective for decades as a primary treatment choice for breast cancer patients expressing the estrogen receptor. However, the issue ...